These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 24950677

  • 21. Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Madelaire C, Schou M, Nelveg-Kristensen KE, Schmiegelow M, Torp-Pedersen C, Gustafsson F, Køber L, Gislason G.
    Int J Cardiol; 2016 Oct 15; 221():944-50. PubMed ID: 27441473
    [Abstract] [Full Text] [Related]

  • 22. Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis.
    Chang CH, Lin JW, Chiu FC, Caffrey JL, Wu LC, Lai MS.
    Circ Arrhythm Electrophysiol; 2014 Feb 15; 7(1):76-82. PubMed ID: 24446025
    [Abstract] [Full Text] [Related]

  • 23. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
    Adedinsewo D, Xu J, Agasthi P, Oderinde A, Adekeye O, Sachdeva R, Rust G, Onwuanyi A.
    Circ Arrhythm Electrophysiol; 2017 May 15; 10(5):e004573. PubMed ID: 28500174
    [Abstract] [Full Text] [Related]

  • 24. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 15; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 25. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S, Yang YM, Zhu J, Ren JM, Wang J, Zhang H, Shao XH.
    Am J Emerg Med; 2017 Nov 15; 35(11):1589-1594. PubMed ID: 28551087
    [Abstract] [Full Text] [Related]

  • 26. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation.
    Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Pilote L.
    Circulation; 2012 Dec 04; 126(23):2680-7. PubMed ID: 23124034
    [Abstract] [Full Text] [Related]

  • 27. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    Allen LA, Fonarow GC, Simon DN, Thomas LE, Marzec LN, Pokorney SD, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Chang P, Peterson ED, Piccini JP, ORBIT-AF Investigators.
    J Am Coll Cardiol; 2015 Jun 30; 65(25):2691-8. PubMed ID: 26112191
    [Abstract] [Full Text] [Related]

  • 28. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RP.
    J Am Heart Assoc; 2017 Jun 30; 6(7):. PubMed ID: 28666993
    [Abstract] [Full Text] [Related]

  • 29. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Lip GY.
    Eur J Heart Fail; 2013 Apr 30; 15(4):415-24. PubMed ID: 23302606
    [Abstract] [Full Text] [Related]

  • 30. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J, Kałużna-Oleksy M, Nessler J, Opolski G, Crespo-Leiro MG, Maggioni AP, Grajek S, Ponikowski P, Drożdż J, Straburzyńska-Migaj E.
    Kardiol Pol; 2018 Apr 30; 76(7):1064-1072. PubMed ID: 29476617
    [Abstract] [Full Text] [Related]

  • 31. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA, CHARM Investigators.
    J Am Coll Cardiol; 2006 May 16; 47(10):1997-2004. PubMed ID: 16697316
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
    Botis M, Kartas A, Samaras A, Akrivos E, Vrana E, Liampas E, Papazoglou AS, Moysidis DV, Papanastasiou A, Baroutidou A, Karvounis H, Tzikas A, Parissis J, Drakos SG, Giannakoulas G.
    Hellenic J Cardiol; 2022 May 16; 68():25-32. PubMed ID: 36037999
    [Abstract] [Full Text] [Related]

  • 33. Interaction between digoxin and dronedarone in the PALLAS trial.
    Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ, PALLAS investigators.
    Circ Arrhythm Electrophysiol; 2014 Dec 16; 7(6):1019-25. PubMed ID: 25378467
    [Abstract] [Full Text] [Related]

  • 34. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.
    J Hypertens; 2015 Jul 16; 33(7):1480-6. PubMed ID: 25799208
    [Abstract] [Full Text] [Related]

  • 35. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA.
    Circulation; 2015 Oct 27; 132(17):1604-12. PubMed ID: 26384160
    [Abstract] [Full Text] [Related]

  • 36. Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry.
    Baldasseroni S, Orso F, Fabbri G, De Bernardi A, Cirrincione V, Gonzini L, Fumagalli S, Marchionni N, Midi P, Maggioni AP, Italian Network on Congestive Heart Failure Investigators.
    Cardiology; 2010 Oct 27; 116(2):79-88. PubMed ID: 20516683
    [Abstract] [Full Text] [Related]

  • 37. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U, Benson L, Edner M, Dahlström U, Lund LH.
    Circ Heart Fail; 2015 Mar 27; 8(2):252-60. PubMed ID: 25575580
    [Abstract] [Full Text] [Related]

  • 38. Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure　- A Nationwide Cohort Study.
    Yu HT, Yang PS, Lee H, You SC, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B.
    Circ J; 2018 Feb 23; 82(3):652-658. PubMed ID: 29142156
    [Abstract] [Full Text] [Related]

  • 39. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.
    Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Guo H, Pilote L.
    Circulation; 2014 Mar 18; 129(11):1196-203. PubMed ID: 24452752
    [Abstract] [Full Text] [Related]

  • 40. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G, Devasenapathy N, Zühlke L, Engel ME, Rangarajan S, Teo KK, Mayosi BM, Yusuf S, Global Rheumatic Heart Disease Registry (REMEDY) Investigators.
    Heart; 2019 Mar 18; 105(5):363-369. PubMed ID: 30209123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.